As shown in Figure 3B, concentration of S100‐A9 was significantly higher in FF‐Exos of PCOS patients compared with controls, whereas no significant difference was found in the supernatant of follicular fluid between PCOS and control group. Here, S100A9 is linked to polycystic ovary syndrome.